Navigation Links
Henry Schein to Present at the 2013 Barclays Global Healthcare Conference
Date:3/5/2013

MELVILLE, N.Y., March 5, 2013 /PRNewswire/ -- Henry Schein, Inc. (NASDAQ: HSIC), the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners, announced today that Steven Paladino , Executive Vice President and Chief Financial Officer for Henry Schein , will present at the 2013 Barclays Global Healthcare Conference taking place at the Loews Hotel in Miami, Florida.  

Henry Schein 's presentation is scheduled to begin at 10:45 a.m. EDT on March 12, 2013 and can be heard via live webcast by visiting www.henryschein.com, clicking on "Investor Relations" and following the link for "Webcasts."  A replay will be available on the Web site following the presentation.

About Henry Schein , Inc.

Henry Schein , Inc. is the world's largest provider of health care products and services to office-based dental, medical and animal health practitioners.  The Company also serves dental laboratories, government and institutional health care clinics, and other alternate care sites.  A Fortune 500® Company and a member of the NASDAQ 100® Index, Henry Schein employs more than 15,000 Team Schein Members and serves more than 775,000 customers.

The Company offers a comprehensive selection of products and services, including value-added solutions for operating efficient practices and delivering high-quality care.  Henry Schein operates through a centralized and automated distribution network, with a selection of more than 96,000 branded products and Henry Schein private-brand products in stock, as well as more than 110,000 additional products available as special-order items. The Company also offers its customers exclusive, innovative technology solutions, including practice management software and e-commerce solutions, as well as a broad range of financial services.

Headquartered in Melville, N.Y., Henry Schein has operations or affiliates in 25 countries.  The Company's sales reached a record $8.9 billion in 2012, and have grown at a compound annual rate of 17 percent since Henry Schein became a public company in 1995.  For more information, visit the Henry Schein Web site at www.henryschein.com.


'/>"/>
SOURCE Henry Schein , Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Optimer Pharmaceuticals Board of Directors Appoints Board Chairman, Dr. Henry McKinnell, Chief Executive Officer
2. Henry Schein Acquires The Maddox Practice Group
3. Henry Schein, Supplier Partners Join American Dental Association On Eleventh Annual Give Kids A Smile Day
4. Henry Schein To Present At The Oppenheimer 23rd Annual Healthcare Conference
5. Henry Schein To Present At The NASDAQ OMX 29th Investor Program
6. Henry Schein to Present at the 24th Annual Piper Jaffray Healthcare Conference
7. Henry Schein Announces Featured Speakers For The "Recovery Empowerment Symposium: Emerging From The Storm"
8. Henry Schein To Convene Expert-Led Symposium On Practice Recovery In The Wake Of Hurricane Sandy
9. Henry Schein To Present At The Jefferies 2012 Global Healthcare Conference
10. Henry Schein Expands Support And Guidance To Customers Affected By Hurricane Sandy
11. Henry Schein, Its Supplier Partners and The Henry Schein Cares Foundation Commit to Donate More Than $1 Million to Relief Efforts for Hurricane Sandy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/12/2017)... July 12, 2017  Eli Lilly and Company (NYSE: ... generic companies to resolve pending patent litigation in the U.S. ... regarding the Cialis ® (tadalafil) unit dose ... 26, 2020. As part of the agreement, Cialis exclusivity is ... 2018. "The unit dose patent for Cialis is ...
(Date:7/11/2017)... , July 11, 2017  Sysmex America, ... urinalysis diagnostic testing equipment as well as middleware ... a way to make quality assurance easier and ... "Sysmex is well known for the innovation that ... Quality Monitor elevates quality assurance processes to a ...
(Date:7/10/2017)... -- The Institute for In Vitro Sciences (IIVS), a ... a VITROCELL® inhalation exposure system thanks to a generous ... which is designed to replace animals in inhalation testing, ... airborne test materials in an environment that mimics the ... testing combustible tobacco products, as well as next generation ...
Breaking Medicine Technology:
(Date:7/26/2017)... ... ... An inventor from Salisbury, N.C., knows the difficulties involved with leech therapy. "I ... to keep leeches in place during therapy," she said. "That’s why I came up ... to keep a leech in place on the skin during therapy. It prevents the ...
(Date:7/26/2017)... ... July 26, 2017 , ... Written By: Ashley D. Beall, ... in drug therapy for patients living with relapsing and primary multiple sclerosis that ... cell targeted therapy that has been proven to significantly reduce signs of disease ...
(Date:7/26/2017)... ... July 26, 2017 , ... Evergreen Healthcare ... of their continued efforts to provide innovative offerings to their healthcare partners. These ... and build dynamic, high-performing teams to address healthcare IT’s biggest challenges. , “Adding ...
(Date:7/26/2017)... ... July 26, 2017 , ... It may be hard to ... accessible to people in the third world. Diseases that many developed countries consider rare ... who don't have access to vaccines. , On an upcoming segment of "Success Files", ...
(Date:7/26/2017)... ... July 26, 2017 , ... ... 2017 Process Validation and Process Validation Statistics Conferences in Bethesda, Maryland, 12 ... lifecycle challenges faced by process validation professionals and statisticians today. , “These ...
Breaking Medicine News(10 mins):